“El hombre que interroga a cada cáncer hasta saber cómo matarlo”
Search Results for:
Joan Montero, a senior researcher in IBEC’s Nanobioengineering group, appeared yesterday in an interview published by the SINC Agency in which he talks about his laboratory test – which is already being used in some hospitals in the United States – which is capable of predicting, in just 24 hours, if a drug will be able to kill a tumor.Tackling challenges to research excellence
Last month IBEC Director Josep Samitier was one of the panelists in a round table organised by the Cercle de Salut, an association devoted to improving the health system so that it may respond adequately to the challenges posed by society.
Last month IBEC Director Josep Samitier was one of the panelists in a round table organised by the Cercle de Salut, an association devoted to improving the health system so that it may respond adequately to the challenges posed by society.In the discussion at the Parc de Recerca Biomèdica de Barcelona (PRBB) entitled ‘L’excel·lència en la recerca, reptes immediats’, Josep and the other participants – ISGlobal director Antoni Plasencia and IrsiCaixa director Bonaventura Clotet – discussed the current situation of biomedical research in Catalonia. In particular, the hot topic under discussion was the impact that recent regulatory and administrative changes may have on its competitiveness.
Inspiration from a carpenter’s toolbox
IBEC’s Smart-Nano-Bio-Devices and Nanobioengineering groups have joined forces to solve the problem of random movement of micro- and nanomotors.
IBEC’s Smart-Nano-Bio-Devices and Nanobioengineering groups have joined forces to solve the problem of random movement of micro- and nanomotors.Samuel Sanchez’s group has been forging ahead with its creation of self-propelling micro- and nanodevices in the last few years. These chemically powered ‘swimmers’ are self-propelled by catalytic reactions in fluids – which could be the fluids of our body, or water – and have a number of promising applications, such as targeted drug delivery, environmental remediation, or as pick-up and delivery agents in lab-on-a-chip devices.
IBEC Seminar: Cristina Canal
Cold atmospheric plasma: a novel potential therapy for cancer treatment
IBEC Seminar: Cristina Canal
Cold atmospheric plasma: a novel potential therapy for cancer treatment
IBEC Seminar: Cristina Canal
Cold atmospheric plasma: a novel potential therapy for cancer treatment
IBEC Seminar: Cristina Canal
Cold atmospheric plasma: a novel potential therapy for cancer treatment
“Ja es comença a dir que no hi ha malaties, sinó malalts”
An interview with IBEC director Josep Samitier in his capacity as the president of ACER appeared in the ‘Dominical’ supplement of the Diari de Girona last week.
An interview with IBEC director Josep Samitier in his capacity as the president of ACER appeared in the ‘Dominical’ supplement of the Diari de Girona last week.Prize for IBEC in Technology Transfer competition
An IBEC project pitch won third prize in a Technology Transfer Competition at last week’s Onco Emergence Forum.
An IBEC project pitch won third prize in a Technology Transfer Competition at last week’s Onco Emergence Forum.The project, which is the brainchild of IBEC group leader Pere Roca-Cusachs and proposes the targeting of tumor mechanics to develop new drugs for oncology, specifically with pancreatic cancer in mind, was pitched by IBEC Technology Transfer manager Diana Gonzalez at the meeting on Friday.
Diana, involved in the project from its onset, was one of twelve finalists chosen to present in six-minute pitches to a panel of judges. The project was shortlisted because of its solid focus on an unmet medical, market or patient need, and because it proposed using innovative technology to create a product or service.
IBEC researchers take to the stage at second BIST conference
Today more than 300 researchers are meeting at CosmoCaixa to debate the latest scientific advances in cutting-edge fields at the yearly conference of the Barcelona Institute of Science and Technology (BIST).
Today more than 300 researchers are meeting at CosmoCaixa to debate the latest scientific advances in cutting-edge fields at the yearly conference of the Barcelona Institute of Science and Technology (BIST).The gathering, promoted by the “la Caixa” Banking Foundation – which currently holds the vice-presidency of the BIST Board of Trustees – kicked off with a keynote speech by US scientist Barry C. Barish, winner of the 2017 Nobel Prize in Physics, entitled ‘Gravitational Waves: From Einstein to a New Science’.